|
|
Volumn 29, Issue 11, 1999, Pages 1064-1075
|
|
Anticoagulants: When, which, how, how much, until when; these are still the questions. I;Anticoagulantes: Cuando, cual, como, cuanto, hasta cuando; esta sigue siendo la cuestion. I
a
a
NONE
(Argentina)
|
|
Author keywords
Anticoagulation; Aortoembolic; Atherothrombosis; Cardioembolic; Heparin; Stroke
|
|
Indexed keywords
ANTICOAGULANT AGENT;
FIBRINOLYTIC AGENT;
HEPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
PHOSPHOLIPID ANTIBODY;
ANTICOAGULANT THERAPY;
BRAIN HEMORRHAGE;
BRAIN ISCHEMIA;
DRUG EFFICACY;
DRUG INDICATION;
EVIDENCE BASED MEDICINE;
FIBRINOLYTIC THERAPY;
HUMAN;
REVIEW;
STROKE;
TREATMENT OUTCOME;
AGED;
CEREBROVASCULAR DISEASE;
HISTORY;
IMMUNOLOGY;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
AGED;
ANTIBODIES, ANTIPHOSPHOLIPID;
ANTICOAGULANTS;
CEREBROVASCULAR DISORDERS;
HEPARIN;
HISTORY, 20TH CENTURY;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
TREATMENT OUTCOME;
|
|
EID: 0033375671
PISSN: 02100010
EISSN: None
Source Type: Journal
DOI: 10.33588/rn.2911.99129 Document Type: Review |
|
Times cited : (2)
|
|
References (98)
|
